AlfaSigma (Morpho CDMO)
Bologna, Italy
Program data pending ClinicalTrials.gov matching
60.0
Signal Score
○ FDA Inspections
○ Clinical Trials
○ SEC Filings
○ Press
○ EMA GMP
○ MHRA GMP
Quick Facts: AlfaSigma (Morpho CDMO)
- Signal Score
- 60.0/100
- Quality Compliance
- Assessment pending
- Headquarters
- Bologna, Italy
- Modalities
- Sterile Injectables (liquid, lyophilized, aseptic), Vaccines, Sterile Hormonal Products, Oral Solid Dose, Semi-Solids, Non-Sterile Liquids, Pressurized Foams, Fine Chemicals / Carnitine Derivatives (Biosint)
- Active Programs
- No ClinicalTrials.gov matches confirmed
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
- Scored By
- CDMO Signal — independent CDMO intelligence platform
About AlfaSigma (Morpho CDMO)
Auto-created by AI matchmaker. Data verification pending.
Signal Score & Pillar Breakdown
Quality Compliance
—
No FDA inspection records found. This CDMO may operate under a different legal name or may not have US FDA-inspected facilities.
FDA InspectionsNo US records on file
No FDA inspection records found for this manufacturer
Quality score requires FDA inspection data
Operations
—
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs
— no verified data
Sponsors— no verified data
ModalitiesSterile Injectables (liquid, lyophilized, aseptic), Vaccines, Sterile Hormonal Products, Oral Solid Dose, Semi-Solids, Non-Sterile Liquids, Pressurized Foams, Fine Chemicals / Carnitine Derivatives (Biosint)
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Data sourced from ClinicalTrials.gov, FDA, SEC EDGAR, and verified press only. No unverified estimates shown.
Financial Stability
60.0
Private company
Financial assessment: 60.0/100
Source: SEC EDGAR, press monitoring
Profile-based financial assessment
SEC FilingsPrivate company
Private company
Financial assessment: 60.0/100
Capacity
60.0
Broad modality coverage (8 modalities)
Source: SEC EDGAR, press monitoring, company profiles
Profile-based capacity assessment
Broad modality coverage (8 modalities)
Frequently Asked Questions About AlfaSigma (Morpho CDMO)
What is AlfaSigma (Morpho CDMO)'s CDMO Signal Score?
AlfaSigma (Morpho CDMO) has a Signal Score of 60/100, based on quality, operations, financial stability, and capacity data.
Evaluating AlfaSigma (Morpho CDMO) for a manufacturing program?
Use the free AI matchmaker to compare AlfaSigma (Morpho CDMO) against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
Similar CDMOs
BioCina
Adelaide, Australia
Biologics (Microbial), Plasmid DNA, mRNA, LNP, Sterile Fill-Finish, Recombinant Proteins, Vaccines, Biosimilars, High Potency/Oncology Injectables, Blow-Fill-Seal
Bryllan LLC
Brighton, MI
Sterile Fill-Finish, Aseptic Powder & Liquid Filling, Biologics (Injectables), Potent/Cytotoxic Compounds, Hormones, mAbs/Antibodies, Live Viruses, Vaccines, Drug-Device Combination Products (Syringes, IV Bags, Cartridges)
53Biologics
Boecillo, Valladolid, Spain
Biologics, Recombinant Proteins, Plasmid DNA, mRNA, Enzymes, Vaccines, Antibody Fragments
Argonaut Manufacturing Services
Carlsbad, CA
Aseptic Fill/Finish, Biologics (injectable), mAbs, Peptides, Small Molecules, Vaccines, IVD/Diagnostics, Lyophilization
Sun Pharmaceutical Industries Ltd.
Mumbai, India
Small Molecule API, Oral Solid Dose, Sterile Injectables, Specialty Generics, Novel Chemical Entities (NCE) via CRAMS, Biologics (via CMO partnerships), Specialty/Innovative Medicines